Taysha Gene Therapies Inc Live Stock Price Today, Share Analysis and Chart

Name: Taysha Gene Therapies Inc: Is Infosys Ltd. worth buying?
Item: Taysha Gene Therapies Inc
Rating: 2.06300
Author: Trendlyne DVM scores

about

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large...

5.31 -0.14 (-2.57%)

New 52W High in past week

3.7M

XNAS Volume

XNAS 09 Dec, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

6.0 / 100

Technically Bullish

76.5 / 100

1Yr Price target upside is 99%

14 analysts

Taysha Gene Therapies Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Taysha Gene Therapies Inc Live Stock Price Today, Share Analysis and Chart

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large...

New 52W High in past week

SWOT Analysis

Taysha Gene Therapies Inc Live Price Chart